Evicita · Supplement evidence, graded and cited · Supplements · Lifestyle · Mechanisms · Lab tests · 中文

Micronized purified flavonoid fraction

Micronized Purified Flavonoid Fraction (MPFF / Diosmin) · also known as Diosmin, Hesperidin, Daflon, MPFF, Diosmin

Micronized purified flavonoid fraction (mainly diosmin) is supported by a fair number of randomized trials and meta-analyses. It can ease leg heaviness and swelling in chronic venous insufficiency, as well as the symptoms of acute hemorrhoid flare-ups. Human studies have observed improved microcirculation, but the venous tone and anti-inflammatory mechanisms come mainly from animal and cell studies.

Typical dose: Micronized purified flavonoid fraction (about 90% diosmin, the rest being other flavonoids expressed as hesperidin) 500–1000 mg/day, taken with meals.
Absorption and forms: Ordinary diosmin granules are coarse and poorly soluble in water. Micronization (median particle diameter under 2 μm) improves dissolution and absorption to some extent. Diosmin has to be converted in the intestine, so its absorption and metabolism are complex, and human data on how much is absorbed are limited. Split the daily amount between breakfast and dinner.

Clinical uses and human evidence

Varicose veins and leg swelling

BeneficialGrade A · Strong evidence
Studies (2)
  1. Kakkos 2018 · Int Angiol · Meta-analysis · n=1692 — Efficacy of micronized purified flavonoid fraction (Daflon®) on improving individual symptoms, signs and quality of life in patients with chronic venous disease: a systematic review and meta-analysis of randomized double-blind placebo-controlled trials
  2. Sheikh 2020 · Adv Ther · Meta-analysis — Micronized Purified Flavonoid Fraction in Hemorrhoid Disease: A Systematic Review and Meta-Analysis

Mechanisms of action

Endothelial nitric oxide synthase (eNOS) coupling and NO vasodilation

★★★☆☆Mechanism evidence: grade CSecondary target

Animal studies show that high-dose diosmin can improve vascular function markers linked to nitric oxide synthase. This result does not explain changes in venous tone, though, and no trial has shown that the venous tone effect of MPFF in humans is mediated by eNOS and nitric oxide.

References (2)
  1. Saengnak 2025 · Rat study: high-dose diosmin improved vascular function and NOS3-related markers in a nitric oxide synthase inhibition model
  2. Literature search · No direct study: no reliable human trial has confirmed that the venous tone effect of MPFF is mediated by eNOS/NO

Platelet-activating factor (PAF) antagonism and improved microcirculatory rheology

★★☆☆☆Mechanism evidence: grade BSecondary target

A small human study observed that micronized flavonoids can increase red blood cell velocity in ankle capillaries, and improved capillary permeability has been reported. These results do not prove PAF receptor antagonism, and claims about leukocyte adhesion and ICAM-1 also lack human evidence.

References (2)
  1. Allegra 1995 · Open-label study of 24 people: red blood cell velocity in ankle capillaries rose after 1 g/day of MPFF; an improvement in red cell deformability is only speculative
  2. Olszewski 2000 · Review of clinical studies: reports improved capillary permeability in small randomized trials

Safety and drug interactions

Generally well tolerated at usual doses. Mild digestive effects such as acid reflux and nausea occur occasionally. Taking it with meals helps somewhat but does not fully prevent them.
Open in the interactive app ›